CH638537A5 - Water-soluble corticoids - Google Patents

Water-soluble corticoids Download PDF

Info

Publication number
CH638537A5
CH638537A5 CH357378A CH357378A CH638537A5 CH 638537 A5 CH638537 A5 CH 638537A5 CH 357378 A CH357378 A CH 357378A CH 357378 A CH357378 A CH 357378A CH 638537 A5 CH638537 A5 CH 638537A5
Authority
CH
Switzerland
Prior art keywords
methyl
dioxo
hydroxy
pregnadien
compound according
Prior art date
Application number
CH357378A
Other languages
German (de)
English (en)
Inventor
Ulrich Kerb
Rudolf Wiechert
Joachim-Friedrich Kapp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH638537A5 publication Critical patent/CH638537A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
CH357378A 1977-04-06 1978-04-03 Water-soluble corticoids CH638537A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772715853 DE2715853A1 (de) 1977-04-06 1977-04-06 Wasserloesliche kortikoide

Publications (1)

Publication Number Publication Date
CH638537A5 true CH638537A5 (en) 1983-09-30

Family

ID=6005979

Family Applications (1)

Application Number Title Priority Date Filing Date
CH357378A CH638537A5 (en) 1977-04-06 1978-04-03 Water-soluble corticoids

Country Status (29)

Country Link
JP (1) JPS53149963A (pt)
AT (1) ATA239978A (pt)
AU (1) AU3481178A (pt)
BE (1) BE865760A (pt)
BG (1) BG28578A3 (pt)
CA (1) CA1113452A (pt)
CH (1) CH638537A5 (pt)
CS (1) CS198295B2 (pt)
DD (1) DD135082A5 (pt)
DE (1) DE2715853A1 (pt)
DK (1) DK153378A (pt)
EG (1) EG13249A (pt)
ES (1) ES468572A1 (pt)
FI (1) FI781053A (pt)
FR (1) FR2386557A1 (pt)
GB (1) GB1602266A (pt)
IE (1) IE46602B1 (pt)
IL (1) IL54443A0 (pt)
IT (1) IT1094296B (pt)
LU (1) LU79375A1 (pt)
NL (1) NL7803188A (pt)
NO (1) NO781200L (pt)
NZ (1) NZ186745A (pt)
PL (1) PL114096B1 (pt)
PT (1) PT67872B (pt)
RO (1) RO81076A2 (pt)
SE (1) SE7803837L (pt)
SU (1) SU668611A3 (pt)
ZA (1) ZA781977B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948533A (en) * 1984-03-28 1990-08-14 The Upjohn Company 11a-hydroxy steroid diester

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1169444B (de) * 1961-02-22 1964-05-06 Schering Ag Verfahren zur Herstellung von ?-16ª‡-Methylsteroiden
YU34304B (en) * 1968-08-17 1979-04-30 Schering Ag Process for preparing corticoid-21-mono-phosphates
DK290774A (pt) * 1973-06-08 1975-02-03 Schering Ag

Also Published As

Publication number Publication date
CS198295B2 (en) 1980-05-30
IT7821995A0 (it) 1978-04-05
RO81076A2 (ro) 1983-02-01
ATA239978A (de) 1981-06-15
IL54443A0 (en) 1978-07-31
CA1113452A (en) 1981-12-01
EG13249A (en) 1980-12-31
IT1094296B (it) 1985-07-26
SE7803837L (sv) 1978-10-07
PT67872A (fr) 1978-05-01
IE46602B1 (en) 1983-07-27
BE865760A (fr) 1978-10-06
LU79375A1 (de) 1978-07-13
PT67872B (fr) 1979-11-14
JPS53149963A (en) 1978-12-27
DD135082A5 (de) 1979-04-11
PL114096B1 (en) 1981-01-31
DK153378A (da) 1978-10-07
AU3481178A (en) 1979-10-11
FR2386557B1 (pt) 1980-02-01
FI781053A (fi) 1978-10-07
RO81076B1 (ro) 1983-01-30
NL7803188A (nl) 1978-10-10
GB1602266A (en) 1981-11-11
NO781200L (no) 1978-10-09
FR2386557A1 (fr) 1978-11-03
SU668611A3 (ru) 1979-06-15
BG28578A3 (bg) 1980-05-15
PL205800A1 (pl) 1979-01-29
ZA781977B (en) 1979-03-28
ES468572A1 (es) 1978-12-01
DE2715853A1 (de) 1978-10-19
IE780672L (en) 1978-10-06
NZ186745A (en) 1980-10-24

Similar Documents

Publication Publication Date Title
DD235450A1 (de) Verfahren zur herstellung neuer 1-(2-hydroxyaryl)alkan-1-on-oxime
CH640249A5 (de) Germaniumhaltiges organisches polymer und verfahren zu seiner herstellung.
DE3342624A1 (de) Benzaronderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE2714129A1 (de) Prostaglandinderivate, verfahren zu deren herstellung und deren verwendung
DE1804691B2 (de) Taurocholensaeurederivate
EP0100516B1 (de) 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD95565B1 (de) Verfahren zur herstellung neuer pregnansaeurederivate
DE2337067A1 (de) Indensaeure-glucuronide
CH638537A5 (en) Water-soluble corticoids
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2337882C3 (de) Bis-Piperazino-Androstan-Derivate und Verfahren zu ihrer Herstellung
DE3116891C2 (pt)
DE2500808B2 (de) 4-cyclopropylmethylenoxy-3-chlorphenylessigsaeure und ihre salze, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE2348197C3 (de) Norethisteron-O-alkyloxime, Verfahren zu ihrer Herstellung sowie ihre Verwendung
CH640502A5 (de) 3beta-substituierte 18beta-olean-9-en-30-oylsaeurederivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben.
DE2004301A1 (de) Phenylserinderivate
DE2247828A1 (de) Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
DE2006635C (de) löalpha, 17alpha (propen 2 yhden dioxy) 9 fluor 1 lbeta, 21 dihydroxy Delta hoch 1,4 pregnadiene bzw deren 21 Ester, Verfahren zu ihrer Herstellung und diese als alleinigen Wirkstoff ent haltende pharmazeutische Mittel
DE1518006B2 (pt)
DE2743944A1 (de) 5-alkoxy-picolinsaeuren, verfahren zur herstellung derselben und blutdrucksenkende arzneimittel, welche diese enthalten
DE2612114A1 (de) Prostaglandin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
DE2753838A1 (de) Wasserloesliche kortikoide
DE1468892C (de) Verfahren zur Herstellung von Steroid-21-apocarnphan-l' -carboxylaten mit lokaler antiinflammatorischer Wirkung
DE1941933B2 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-5H-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1468902C (de) 25-Aza-19-nor-l,3,5(10)-cholestatriene und deren therapeutisch verträgliche Säureadditionssalze sowie ein Verfahren zur Herstellung dieser Verbindungen

Legal Events

Date Code Title Description
PL Patent ceased